Realizing brain therapy with “smart medicine”: mechanism and case report of molecular hydrogen inhalation for Parkinson’s disease.
Yusuke Ichikawa, Bunpei Sato, Shin-Ichi Hirano, Yoshiyasu Takefuji, Fumitake Satoh · Medical gas research · 2024
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In the patient, the hands and legs did not shake, or shook slightly, the mouth shook slightly, and the forward-bending posture improved to a reasonably upright state, although the posture was not completely upright, immediately after the hydrogen gas had been inhaled for 90 or 120 minutes per day for about 1 month. These findings add human evidence supporting molecular hydrogen's therapeutic potential for Parkinson's disease.
What the Findings Mean
H2HUBB reviewed how inhaled hydrogen gas affected the outcomes measured in In the midbrain of Parkinson's disease patients, hydroxyl radicals generated by the Fenton reaction cause a chain reaction of oxidation of dopamine, but hydrogen entering the midbrain can convert the. In the patient, the hands and legs did not shake, or shook slightly, the mouth shook slightly, and the forward-bending posture improved to a reasonably upright state, although the posture was not completely upright, immediately after the hydrogen gas had been inhaled for 90 or 120 minutes per day for about 1 month.
What the Researchers Studied
The researchers studied In the midbrain of Parkinson's disease patients, hydroxyl radicals generated by the Fenton reaction cause a chain reaction of oxidation of dopamine, but hydrogen entering the midbrain can convert the.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 4% source-reported H₂ gas concentration; Source-reported hydrogen exposure: 4% source-reported H₂ gas concentration; 120 minutes/day; reported treatment duration: 90 minutes. In the patient, the hands and legs did not shake, or shook slightly, the mouth shook slightly, and the forward-bending posture improved to a reasonably upright state, although the posture was not completely upright, immediately after the hydrogen gas had been inhaled for 90 or 120 minutes per day for about 1 month. The authors concluded that the therapeutic effect of hydrogen on the brain has been introduced in this paper.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential for Parkinson's disease and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a case report. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as case report with human clinical evidence. The research population or model was In the midbrain of Parkinson's disease patients, hydroxyl radicals generated by the Fenton reaction cause a chain reaction of oxidation of dopamine, but hydrogen entering the midbrain can convert the. The hydrogen delivery method was inhaled hydrogen gas. The source-reported hydrogen concentration was 4% source-reported H₂ gas concentration. The reported treatment duration was 90 minutes.
Limitations and Safety
Reported limitations: This is a limitation of modern medicine.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.